214 related articles for article (PubMed ID: 10943268)
1. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up.
Tabár L; Vitak B; Chen HH; Duffy SW; Yen MF; Chiang CF; Krusemo UB; Tot T; Smith RA
Radiol Clin North Am; 2000 Jul; 38(4):625-51. PubMed ID: 10943268
[TBL] [Abstract][Full Text] [Related]
2. Update of the Swedish Two-County Trial of breast cancer screening: histologic grade-specific and age-specific results.
Tabar L; Vitak B; Chen HH; Prevost TC; Duffy SW
Swiss Surg; 1999; 5(5):199-204. PubMed ID: 10546517
[TBL] [Abstract][Full Text] [Related]
3. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial.
Tabar L; Fagerberg G; Chen HH; Duffy SW; Smart CR; Gad A; Smith RA
Cancer; 1995 May; 75(10):2507-17. PubMed ID: 7736395
[TBL] [Abstract][Full Text] [Related]
5. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.
Tabár L; Vitak B; Chen TH; Yen AM; Cohen A; Tot T; Chiu SY; Chen SL; Fann JC; Rosell J; Fohlin H; Smith RA; Duffy SW
Radiology; 2011 Sep; 260(3):658-63. PubMed ID: 21712474
[TBL] [Abstract][Full Text] [Related]
6. Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma.
Tabar L; Tony Chen HH; Amy Yen MF; Tot T; Tung TH; Chen LS; Chiu YH; Duffy SW; Smith RA
Cancer; 2004 Oct; 101(8):1745-59. PubMed ID: 15386334
[TBL] [Abstract][Full Text] [Related]
7. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
Tabár L; Vitak B; Chen HH; Yen MF; Duffy SW; Smith RA
Cancer; 2001 May; 91(9):1724-31. PubMed ID: 11335897
[TBL] [Abstract][Full Text] [Related]
8. New Swedish breast cancer detection results for women aged 40-49.
Tabar L; Duffy SW; Burhenne LW
Cancer; 1993 Aug; 72(4 Suppl):1437-48. PubMed ID: 8339236
[TBL] [Abstract][Full Text] [Related]
9. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point.
Tabar L; Duffy SW; Yen MF; Warwick J; Vitak B; Chen HH; Smith RA
J Med Screen; 2002; 9(4):159-62. PubMed ID: 12518005
[TBL] [Abstract][Full Text] [Related]
10. Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg.
Nyström L; Bjurstam N; Jonsson H; Zackrisson S; Frisell J
J Med Screen; 2017 Mar; 24(1):34-42. PubMed ID: 27306511
[TBL] [Abstract][Full Text] [Related]
11. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
[TBL] [Abstract][Full Text] [Related]
12. Update of the Swedish two-county program of mammographic screening for breast cancer.
Tabàr L; Fagerberg G; Duffy SW; Day NE; Gad A; Gröntoft O
Radiol Clin North Am; 1992 Jan; 30(1):187-210. PubMed ID: 1732926
[TBL] [Abstract][Full Text] [Related]
13. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
Swedish Organised Service Screening Evaluation Group
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585
[TBL] [Abstract][Full Text] [Related]
14. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
Jonsson H; Nyström L; Törnberg S; Lenner P
J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
[TBL] [Abstract][Full Text] [Related]
15. Recent results from the Swedish Two-County Trial: the effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening.
Tabár L; Chen HH; Fagerberg G; Duffy SW; Smith TC
J Natl Cancer Inst Monogr; 1997; (22):43-7. PubMed ID: 9709274
[TBL] [Abstract][Full Text] [Related]
16. Mammographic screening for breast cancer: few new data.
Prescrire Int; 2008 Feb; 17(93):24-7. PubMed ID: 18383654
[TBL] [Abstract][Full Text] [Related]
17. Breast-cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare.
Int J Cancer; 1996 Dec; 68(6):693-9. PubMed ID: 8980168
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of mammography screening: updated overview of the Swedish randomised trials.
Nyström L; Andersson I; Bjurstam N; Frisell J; Nordenskjöld B; Rutqvist LE
Lancet; 2002 Mar; 359(9310):909-19. PubMed ID: 11918907
[TBL] [Abstract][Full Text] [Related]
19. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial.
Tabár L; Faberberg G; Day NE; Holmberg L
Br J Cancer; 1987 May; 55(5):547-51. PubMed ID: 3606947
[TBL] [Abstract][Full Text] [Related]
20. Tumor size and breast cancer detection: what might be the effect of a less sensitive screening tool than mammography?
Duffy SW; Tabar L; Vitak B; Warwick J
Breast J; 2006; 12 Suppl 1():S91-5. PubMed ID: 16430402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]